Skip to main content
. 2021 Aug 28;5(3):115–127. doi: 10.3233/KCA-210119

Fig. 2.

Fig. 2

Trends in receipt of oral anticancer agents in the 12 months following diagnosis with metastatic renal cell carcinoma among SEER-Medicare patients aged 65 and older.